Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Link between ovulation and ovarian cancer
Women who ovulate for longer over their lifetimes have a higher risk of developing ovarian…
Seaweed sugar: trigger immune responses that suppress melanomas
Immunotherapies have improved outcomes of many patients with cancer, including melanoma. But these therapies work for only…
Tiny implantable devices help to kill cancer in mouse models
Many solid tumors resist treatment in part by turning human biology against itself. Tumors surround…
Researchers combine CRISPR gene-editing technology with drug discovery to understand why cancer treatment works
11,000 people are predicted to die from acute myeloid leukemia (AML) in 2019, according to the American Cancer Society. The…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.